Huons Global, the holding company of Huons Group, disclosed on the 13th that operating profit on a consolidation basis last year came to 90.6 billion won, down 6.6% from a year earlier. Revenue for the same period rose 4.2% to 847.5 billion won, hitting an all-time high. Net profit also increased 20.2% to 80.7 billion won.
The company said revenue expanded on the stable growth of its key operating companies. However, the operating margin inched down due to a higher cost ratio stemming from production capacity expansions.
HuM&C, a healthcare packaging and materials specialist corporations, saw revenue on a consolidation basis rise 11% to 52.3 billion won, but operating profit and net profit fell 50% and 58% to 2.5 billion won and 1.4 billion won, respectively. The company cited a temporary increase in costs from initial stabilization expenses tied to the Vietnam plant ramp-up and the process of establishing local operating systems.
Huons Biopharma, the botulinum toxin subsidiary, posted lower overall results, but exports of the botulinum toxin "Hutox" increased 16.7% to 16.4 billion won. The company recently obtained product approval in China and is preparing to enter the local market.
Song Su-yeong, CEO of Huons Global, said, "We achieved record revenue on expanded exports and affiliate growth, but the operating margin declined somewhat due to a higher cost ratio," adding, "This year we will pursue solid management focused on profitability alongside expanded investment in research and development." Song added, "With the introduction of quarterly dividends, we will continue stable shareholder returns."
Meanwhile, fourth-quarter revenue on a consolidation basis rose 10.9% to 224.5 billion won, surpassing 220 billion won for the first time on a quarterly basis. During the same period, operating profit fell 26.0% to 19.4 billion won, while net profit increased 19.8% to 14.3 billion won.
The company decided on a settlement of account cash dividend of 200 won per share. The record date for the dividend is Apr. 3, after the regular shareholders meeting. The total dividend for the 2025 fiscal year, including semiannual and quarterly dividends, is 880 won per share, up 68% from a year earlier. The total dividend amount is 10.7 billion won.
Huons Global will pay a cash dividend of 200 won per quarter starting this year, totaling 800 won annually, and plans to increase the per-share dividend each year through 2028 within a range of 5% to 30%. The dividend funds will be sourced through a reduction-dividend method tied to a decrease in capital surplus, providing shareholders with a tax-exempt benefit.